Drugs / Globulin, Immune
Globulin, Immune
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT00000720 | ? → Apr 1993 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 3 | NCT00000751 | ? → Aug 2007 | HIV infectious disease | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00001999 | — | HIV infectious disease, cytomegalovirus retinitis | American National Red Cross | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Globulin, Immune | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000720 ↗ |
| Known as | immune globulin | “To evaluate the effect of anti-HIV immune serum globulin (HIVIG) versus immune globulin (IVIG) administered during pregnancy and to the newborn, in combination with zidovudine...” NCT00000751 ↗ |
| Known as | IVIG | “To evaluate the effect of anti-HIV immune serum globulin (HIVIG) versus immune globulin (IVIG) administered during pregnancy and to the newborn, in combination with zidovudine...” NCT00000751 ↗1“To evaluate the clinical, immunologic, and virologic effects of oral zidovudine (AZT) plus intravenous immunoglobulin (IVIG) versus AZT plus placebo (albumin).” NCT00000720 ↗ |
| Modality | Protein / enzyme biologic | “pooled human serum immunoglobulin, another name for antibodies” NCT00000720 ↗ |
| Route | Intravenous | “intravenous immunoglobulin (IVIG)” NCT00000720 ↗ |